Use of acid suppression agents following acute, nonvariceal, upper gastrointestinal bleeding

Hospital Pharmacy

Volumn 39, Issue 10, 2004, Pages 970-975

  Nguyen, Cindy M ^a   Barletta, Jeffrey F ^b   Devlin, John W ^c  

^a DETROIT RECEIVING HOSPITAL   (United States)

^b SPECTRUM HEALTH   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Acid supression agents; Proton pump inhibitors; Upper gastrointestinal bleeding

Indexed keywords

ANTIULCER AGENT; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

BOLUS INJECTION; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG CAPSULE; DRUG INFORMATION; DRUG UTILIZATION; HEALTH SURVEY; HOSPITAL PHARMACY; HUMAN; INFORMATION PROCESSING; INTENSIVE CARE; MORTALITY; PHARMACIST; PRACTICE GUIDELINE; RECURRENT DISEASE; REVIEW; STOMACH ACID; SUSPENSION; TABLET; TREATMENT OUTCOME; UNITED STATES; UPPER GASTROINTESTINAL BLEEDING;

EID: 5444249047     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1177/001857870403901008     Document Type: Review

References (31)

1. Erstad BL. Proton-pump Inhibitors for acute peptic ulcer bleeding. Ann Pharmacother. 2001;35:730-40.
2. 2-antagonists for treatment of GI bleeding. Ann Pharmacother. 2003;37:433-7.
3. Kupfer Y, Cappell MS, Tessler S. Acute gastrointestinal bleeding in the intensive care unit. Gastroent Clin N Amer. 2000;29(2):275-307.
4. Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med. 1994;331:717-27.
5. Beejay U, Wolfe MM. Acute gastrointestinal bleeding in the intensive care unit: The gastroenterologist's perspective. Gastroenterol Clin North Am. 2000;29:309-36.
6. Green FW Jr, Kaplan MM, Curtis LE, et al. Effect of acid and pepsin on blood coagulation and platelet aggregation: A possible contributor to prolonged gastroduodenal mucosal hemorrhage. Gastroenterology. 1978;74:38-43.
7. British Society of Gastroenterology Endoscopy Committee. Nonvariceal upper gastrointestinal haemorrhage: Guidelines. Gut. 2002;51(suppl IV): iv1-iv6.
8. Collins R, Langman M. Treatment with histamine-2 antagonists in acute upper gastrointestinal hemorrhage. N Engl J Med. 1985;313:660-6.
9. Walt RP, Cottrell J, Mann SG, et al. Continuous intravenous famotidine for haemorrhage from peptic ulcer. Lancet. 1992;340:1058-62.
10. 2-receptor antagonists in bleeding peptic ulcer. Aliment Pharmacol Ther. 2002;16:1137-42.
11. Merki HS, Halter F, Widler-Smith CH. Diurnal secretory patterns and tolerance during individually titrated infusions of ranitidine. Gastroenterology. 1993;105:748-54.
12. Netzer P, Gaia C, Sandoz M, et al. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours. Am J Gastroenterol. 1999;94:351-7.
13. 2-receptor blocker for maintaining a persistent elevation of gastric pH after colon resection for cancer. Am J Surg. 2004;187:20-23.
14. Brunner G, Chang J. Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: An open randomized controlled trial. Digestion. 1990;45:217-25.
15. Daneshmend TK, Hawkey CJ, Langman MJS, et al. Omeprazole versus placebo for acute upper gastrointestinal bleeding: Randomized double blind controlled trial. BMJ. 1992;304:143-7.
16. Grosso C, Rossi A, Gambitta P, et al. Non-bleeding visible vessel treatment: Perendoscopic injection therapy versus omeprazole infusion. Scand J Gastroenterol. 1995;30:872-5.
17. Lanas A, Artal A, Blas J, et al. Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer. J Clin Gastroenterol. 1995;21:103-6.
18. Villanueva C, Balanzo J, Torras X, et al. Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: A prospective and randomized study. Endoscopy. 1995;27:308-12.
19. Chua RT, Lin HJ, Wang K, et al. Intravenous omeprazole prevents rebleeding in peptic ulcer patients with a non-bleeding visible vessel: A preliminary report of a randomized controlled study. Chin Med J (Taipei). 1996;57:139-45.
20. Khuroo MS, Yattoo GN, Javid G, et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med. 1997;336:1054-8.
21. Schaffalitzky de Muckadell OB, Havelund T, Harling H, et al. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Scand J Gastroenterol. 1997;32:320-7.
22. Hasselgren G, Lind T, Lundell L, et al. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Scand J Gastroenterol. 1997;32:328-33.
23. Tseng GY, Lin HJ, Lin HY, et al. The influence of intravenous omeprazole on intragastric pH and outcomes in patients with peptic ulcer bleeding after successful endoscopic therapy: A prospective randomized comparative trial. Hepatogastroenterology. 1999;46:2183-8.
24. Lin HJ, Lo WC, Lee FY, et al. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med. 1998;158:54-8.
25. Lau JYW, Sung JJY, Lee KKC, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med. 2000;343;310-16.
26. Javid G, Masoodi I, Zargar SA, et al. Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer. Am J Med. 2001;111:280-4.
27. Fried R, Beglinger C, Stumpf J, et al. Comparison of intravenous pantoprazole with intravenous ranitidine in peptic ulcer bleeding. Gut. 1999;45(suppl 5):A165.
28. 2-antagonists: A meta-analysis of their efficacy in treating bleeding peptic ulcer. Aliment Pharmacol Ther. 2001;15:917-26.
29. Zed PJ, Loewen PS, Slavik RS, et al. Meta-analysis of proton pump inhibitors in treatment of bleeding peptic ulcers. Ann Pharmacother. 2001;35:1528-34.
30. Barkun A, Bardou M, Marshall JK. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2003;139:843-57.
31. Brunner G, Luna P, Hartmann M, et al. Optimizing the intragastric pH as a supportive therapy in upper GI bleeding. Yale J Biol Med. 1996;69:225-31.